- Home
- IRON vs CNMD Comparison
IRON vs CNMD Comparison
Compare IRON & CNMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IRON
- CNMD
- Stock Information
- Founded
- IRON 2017
- CNMD 1970
- Country
- IRON United States
- CNMD United States
- Employees
- IRON N/A
- CNMD N/A
- Industry
- IRON Biotechnology: Pharmaceutical Preparations
- CNMD Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- IRON Health Care
- CNMD Health Care
- Exchange
- IRON Nasdaq
- CNMD Nasdaq
- Market Cap
- IRON 2.1B
- CNMD 1.7B
- IPO Year
- IRON N/A
- CNMD 1987
- Fundamental
- Price
- IRON $67.78
- CNMD $48.17
- Analyst Decision
- IRON Strong Buy
- CNMD Hold
- Analyst Count
- IRON 10
- CNMD 5
- Target Price
- IRON $97.80
- CNMD $59.80
- AVG Volume (30 Days)
- IRON 380.9K
- CNMD 411.2K
- Earning Date
- IRON 11-11-2025
- CNMD 11-05-2025
- Dividend Yield
- IRON N/A
- CNMD 1.66%
- EPS Growth
- IRON N/A
- CNMD 12.82
- EPS
- IRON N/A
- CNMD 3.54
- Revenue
- IRON N/A
- CNMD $1,326,244,000.00
- Revenue This Year
- IRON N/A
- CNMD $6.73
- Revenue Next Year
- IRON N/A
- CNMD $5.45
- P/E Ratio
- IRON N/A
- CNMD $13.59
- Revenue Growth
- IRON N/A
- CNMD 3.94
- 52 Week Low
- IRON $30.82
- CNMD $45.07
- 52 Week High
- IRON $68.79
- CNMD $78.00
- Technical
- Relative Strength Index (RSI)
- IRON 69.97
- CNMD 43.03
- Support Level
- IRON $65.26
- CNMD $45.18
- Resistance Level
- IRON $68.79
- CNMD $47.56
- Average True Range (ATR)
- IRON 2.67
- CNMD 1.72
- MACD
- IRON 0.53
- CNMD -0.21
- Stochastic Oscillator
- IRON 88.97
- CNMD 36.43
About IRON Disc Medicine Inc.
Disc Medicine Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for hematologic diseases. It aims to modify fundamental biological pathways associated with the formation and function of red blood cells, specifically heme biosynthesis and iron homeostasis. Its pipeline includes bitopertin for erythropoietic porphyrias (EPs) including erythropoietic protoporphyria (EPP), X-linked protoporphyria (XLP), and Diamond-Blackfan Anemia (DBA); DISC-0974 for the treatment of anemia of myelofibrosis (MF) and anemia of chronic kidney disease (CKD); and DISC-3405 for the treatment of polycythemia vera (PV) and other hematologic disorders. In addition, the Company's preclinical programs include DISC-0998.
About CNMD CONMED Corporation
Conmed Corp is a Utica, New York-based medical equipment company that focuses on sports medicine procedures and general surgeries. The Company's products are used by surgeons and other healthcare professionals in a variety of specialties including orthopedics, general surgery, gynecology, thoracic surgery and gastroenterology. Geographically operates in USA, Europe, Middle East & Africa, Asia Pacific and North America. Majority is revenue is from USA.